Corleen M. Roche - 06 Aug 2025 Form 3 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Chief Financial Officer
Signature
/s/ Corleen Roche
Issuer symbol
IOVA
Transactions as of
06 Aug 2025
Net transactions value
$0
Form type
3
Filing time
08 Aug 2025, 16:05:17 UTC
Previous filing
16 Apr 2025
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roche Corleen M. Chief Financial Officer C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS /s/ Corleen Roche 08 Aug 2025 0001857905

No securities are beneficially owned.

Remarks:

1. On August 6, 2025, Corleen Roche joined Iovance Biotherapeutics, Inc. as its Chief Financial Officer.